Abstract
The pharmacological treatment of major depressive episodes of bipolar disorder (BD) stands out for its suboptimal efficacy rates, low tolerability and adherence, delayed onset of action, and iatrogenic mood switches. The use of repetitive transcranial magnetic stimulation (rTMS) is as an effective, safe and well-tolerated alternative in the treatment of unipolar and bipolar depressive epi…